Mankind Pharma Limited (BOM:543904)
India · Delayed Price · Currency is INR 2,483.60
-17.00 (-0.68%)
At close: Oct 28, 2026
Mankind Pharma Stock Forecast
Stock Price Forecast
According to 19 analysts polled by S&P Global, Mankind Pharma stock has a consensus rating of "Buy" and an average price target of ₹2,703. The average 1-year stock price forecast is 8.84% higher than the current stock price, while the lowest is ₹2,057 (-17.18%) and the highest is ₹3,280 (+32.07%).
Price Target: ₹2,703 (+8.84%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Mankind Pharma stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 6 | 5 | 5 | 6 | 7 |
| Buy | 8 | 9 | 7 | 7 | 6 | 6 |
| Hold | 1 | 1 | 3 | 3 | 3 | 3 |
| Sell | 3 | 3 | 3 | 3 | 3 | 2 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Total | 20 | 20 | 19 | 19 | 19 | 19 |
Financial Forecast
Revenue This Year
162.90B
from 142.78B
Increased by 14.09%
Revenue Next Year
182.69B
from 162.90B
Increased by 12.15%
EPS This Year
58.84
from 51.96
Increased by 13.23%
EPS Next Year
71.78
from 58.84
Increased by 21.99%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.